Alnylam Pharmaceuticals Overview
Alnylam Pharmaceuticals Target Price
Analysts' 12-month price predictions for ALNY.
Share Price
$149.89
Average Target Price
$234.00
56.1% upside
56.1% upside1 analysts in the last 4 months
High: $234 | Low: $234
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-04-08 | BMO CapitalKostas Biliouris | $234 | 56.1% upside |  |
| 2022-12-15 | Piper SandlerEdward Tenthoff | $253 | 68.8% upside | |
| 2022-07-12 | Cantor FitzgeraldOlivia Brayer | $175 | 16.8% upside | |
| 2022-06-14 | Piper SandlerEdward Tenthoff | $208 | 38.8% upside | |
| 2022-05-02 | H.C. Wainwright | $430 | 186.9% upside | |
| 2022-04-29 | BMO Capital | $166 | 10.7% upside | |
| 2022-04-29 | Citigroup | $211 | 40.8% upside | |
| 2022-04-29 | Leerink Partners | $96 |  36% downside | |
| 2022-04-25 | Morgan Stanley | $178 | 18.8% upside | |
| 2022-02-11 | BMO CapitalGary Nachman | $175 | 16.8% upside | |
| 2022-02-11 | Berenberg BankZhiqiang Shu | $154 | 2.7% upside | |
| 2022-02-10 | RBC CapitalLuca Issi | $225 | 50.1% upside | |
| 2022-02-03 | GuggenheimDebjit Chattopadhyay | $170 | 13.4% upside | |
| 2022-01-26 | Bank of America SecuritiesTazeen Ahmad | $209 | 39.4% upside | |
| 2022-01-23 | JefferiesMaury Raycroft | $205 | 36.8% upside | |
| 2021-12-13 | Cowen & Co.Ritu Baral | $250 | 66.8% upside | |
| 2021-11-22 | Goldman SachsSalveen Richter | $273 | 82.1% upside | |
| 2021-10-29 | Cantor FitzgeraldAlethia Young | $275 | 83.5% upside | |
| 2021-10-29 | UBSEsther Rajavelu | $211 | 40.8% upside | |
| 2021-10-29 | Evercore ISIManeka Mirchandaney | $190 | 26.8% upside | |
| 2021-10-28 | BarclaysGena Wang | $210 | 40.1% upside | |